NL-OMON26193招募中不适用
Fecal Microbiota Transplantation to Preserve Residual Beta Cell Function In Patients With Newly Diagnosed Type 1 Diabetes Mellitus
DFN/DON grant0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
n/a
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients with <6 weeks of new onset type 1 diabetes mellitus and detectable C-peptide levels (aged 18-65 years, BMI 18-30 kg/m2, male/females, no concomitant medication).
排除标准
- •Inability to provide written informed consent
- •Evidence for absent residual betacel function (undetectable C-peptide)
- •Antibiotics use in the last 3 months and proton-pump inhibitor use
- •Evidence for compromised immunity
- •Second auto-immune disease (i.e. coeliac disease, hyper- or hypothyroidism, inflammatory bowel disease)
研究者
相似试验
招募中
2 期
*Fecal Microbiota Transplantation to Preserve Residual Beta Cell Function In Patients With Newly-Diagnosed Type 1 Diabetes Mellitus: The FMT-Preserve-DM1-trial*Type 1 diabetesjuveline diabetes10018424NL-OMON54931Academisch Medisch Centrum34
招募中
不适用
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long- Duration Type 1 Diabetes Mellitustype 1 diabetesNL-OMON27205Amsterdam UMC34
招募中
2 期
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long-Duration Type 1 Diabetes MellitusType 1 diabetes mellitusinsulin-dependent diabetesjuvenile diabetes10018424NL-OMON49429Academisch Medisch Centrum34
招募中
2 期
Fecal microbiota transplantation for intractable gastrointestinal diseases(FEMIGI study)1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associatJPRN-jRCTs041190021Ohmiya Naoki50
撤回
2 期
Fecal Microbiota Transplantation for eradication of Vancomycin-resistant Enterococci (FAVOR): a pilot studyCarriage of vancomycin-resistant Enterococvancomycin-resistant Enterococ carrier10004018NL-OMON46675niversitair Medisch Centrum Utrecht10